Fremanezumab
Original notice title
Czechia – Analgesics – Fremanezumab
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
20 / 100
Risk factors
No procurement documents were analyzed. Bidders must access documents via buyer profile to understand technical specifi...
Structured data marks the contract as EU-funded, but the XML notice indicates no EU funds. This could affect payment te...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- CZK 31.3M estimated value
- Supplies contract
- 1 lot
- Duration 48 MONTH
- Supply of Fremanezumab (analgesic) to the hospital in Prague
- Duration: 48 months
Show full summary
Open tender for the supply of the medicinal product Fremanezumab to the Central Military Hospital – Military University Hospital Prague for 48 months. Awarded based on lowest price (100% weight). Estimated value 31,300,948.80 CZK. Electronic submission required. Only one lot. No procurement documents were analyzed; only the published notice and XML are available.
Risks
No procurement documents were analyzed. Bidders must access documents via buyer profile to understand technical specifi...
Structured data marks the contract as EU-funded, but the XML notice indicates no EU funds. This could affect payment te...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Administrative
- Electronic submission required via the NEN profile
- Bids submitted in Czech or Slovak (languages detected in notice)
- Must provide the medicinal product Fremanezumab as specified in the procurement documents (not analyzed)
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Praha 6, CZE
Website
Buyer profile
Identifier
61383082
Activity
Health
Lots (1)
LOT-0001
Fremanezumab
Supply of the medicinal product containing the active substance Fremanezumab for the Central Military Hospital – Military University Hospital Prague.
EUR 1.3M
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Nejnižší nabídková cena
Value note
Show original TED data
Original TED description
Předmětem této veřejné zakázky jsou průběžné dodávky léčivého přípravku s léčivou látkou FREMANEZUMAB pro potřeby Ústřední vojenské nemocnice – Vojenské fakultní nemocnice Praha v souladu se zadávacími podmínkami
Procurement Details
- Publication date
- 06 Jul 2026
- Languages
- Czech
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 464950-2026
Documents (1)
Similar tenders
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
20 / 100
Risk factors
No procurement documents were analyzed. Bidders must access documents via buyer profile to understand technical specifi...
Structured data marks the contract as EU-funded, but the XML notice indicates no EU funds. This could affect payment te...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications